Aurobindo Pharma Ltd. Company Cash Flow Statement & Analysis

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Profit Before Tax	2,358.45	2,402.92	1,614.35	1,637.48	4,193.01
Net CashFlow-Operating Activity	1,645.79	1,714.80	1,821.16	3,726.71	2,994.41
Net Cash Used In Investing Activity	-2,065.90	-159.96	-3,459.68	-1,613.51	-2,648.73
NetCash Used in Fin. Activity	616.31	-1,837.03	1,719.48	-2,447.54	-27.94
Net Inc/Dec In Cash And Equivlnt	211.94	-273.81	81.44	-335.37	316.23
Cash And Equivalnt Begin of Year	83.32	357.13	48.21	383.58	67.35
Cash And Equivalnt End Of Year	295.26	83.32	129.65	48.21	383.58

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article